Trials built for the age of innovation

Personalized medicine offers tremendous hope for patients. This change in focus to specialty treatments for highly defined patient populations also requires a change in how research works, customized just as specifically as the treatments it is designed to test.

Contact Us

57 orphan drugs

Number of drugs with orphan indications approved in the U.S. between January and August 2018
"Orphan Drugs in the United States: Growth Trends in Rare Disease Treatments", IQVIA Institute for Human Data Science, October 2018

15 oncology drugs

The number of new oncology therapeutics launched in 2018
"Global Oncology Trends 2019", IQVIA Institute for Human Data Science, May 2019

$452 billion

Projected value of the biologics market in 2022
"Advancing Biosimilar Sustainability in Europe", IQVIA Institute for Human Data Science, September 2018
IQVIA Outcomes

30% improvement

in non-enrolling sites with CORE-powered studies
IQVIA Analytics Center of Excellence

Powering change with the IQVIA CORE

IQVIA combines deep therapeutic and scientific knowledge with unmatched experience in clinical trial design and execution. Using the IQVIA CORE we can integrate data, analytics, and technology around the specific requirements of your trial. So we can anticipated challenges, ask the right questions and help you

  • Reach milestones faster: From identifying trial sites that are likely to succeed, to recruiting the right patients 
  • Be more precise: From choosing indications, to comparing scenarios and analyzing key metrics to drive better decisions
  • Leverage the expertise you need: From artificial intelligence and machine learning, to experts in local markets around the world
clinical trial solutions
Protocol Design

Assess your protocol against real world evidence using advanced analytics, and reduce the risk of costly amendments.

Phase I Trials

Leverage a global network of Phase I clinical pharmacology units to build diversity in patient populations and access a range of geographic regions for early clinical development (ECD) programs.

Phase IIb/III Trials

Improve the performance of your clinical trials with the power of the IQVIA CORE.

Site Identification

Identify the best performing sites for your trial in less time with new machine learning and predictive modeling methods.

Patient Recruitment

Predict enrollment more accurately and increase the number of patients per site using data-driven patient recruitment solutions.

Global Laboratories

Access central labs around the globe through Q² Solutions, a joint venture between IQVIA and Quest Diagnostics.

IQVIA Outcomes

30% improvement

in non-enrolling sites with CORE-powered studies
IQVIA Analytics Center of Excellence
New thinking about clinical trials
Related solutions
Functional Services

Decrease clinical development costs and increase study quality using our global functional resources and flexible services, and get more value from your R&D spend.

Virtual Trials

Bring trials directly to patients to decrease costs, increase quality and improve access.

Consulting

Discover unrealized connections and manage your product across the entire lifecycle, from research and development, compliance to launch and commercialization.

Contact Us
Contact Us

Email Us

Get in touch today to discover the right solutions for you.

Call Us

We are pleased to speak with you during our standard business hours.

U.S. Toll-Free only
+1 866 267 4479

For international call please find a number in our toll-free list.